These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 34075536)

  • 1. Ang(1-7) exerts Nrf2-mediated neuroprotection against amyloid beta-induced cognitive deficits in rodents.
    Varshney V; Garabadu D
    Mol Biol Rep; 2021 May; 48(5):4319-4331. PubMed ID: 34075536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naringin Exhibits Mas Receptor-Mediated Neuroprotection Against Amyloid Beta-Induced Cognitive Deficits and Mitochondrial Toxicity in Rat Brain.
    Varshney V; Garabadu D
    Neurotox Res; 2021 Aug; 39(4):1023-1043. PubMed ID: 33534126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quercetin Exhibits α7nAChR/Nrf2/HO-1-Mediated Neuroprotection Against STZ-Induced Mitochondrial Toxicity and Cognitive Impairments in Experimental Rodents.
    Singh NK; Garabadu D
    Neurotox Res; 2021 Dec; 39(6):1859-1879. PubMed ID: 34554409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exendin-4 attenuates brain mitochondrial toxicity through PI3K/Akt-dependent pathway in amyloid beta (1-42)-induced cognitive deficit rats.
    Garabadu D; Verma J
    Neurochem Int; 2019 Sep; 128():39-49. PubMed ID: 31004737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ang (1-7)/Mas receptor-axis activation promotes amyloid beta-induced altered mitochondrial bioenergetics in discrete brain regions of Alzheimer's disease-like rats.
    Varshney V; Garabadu D
    Neuropeptides; 2021 Apr; 86():102122. PubMed ID: 33508525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Nrf2 signaling by sitagliptin and quercetin combination against β-amyloid induced Alzheimer's disease in rats.
    Li Y; Tian Q; Li Z; Dang M; Lin Y; Hou X
    Drug Dev Res; 2019 Sep; 80(6):837-845. PubMed ID: 31301179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhizophora mucronata attenuates beta-amyloid induced cognitive dysfunction, oxidative stress and cholinergic deficit in Alzheimer's disease animal model.
    Suganthy N; Malar DS; Devi KP
    Metab Brain Dis; 2016 Aug; 31(4):937-49. PubMed ID: 27188290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineralocorticoid receptor antagonist-mediated cognitive improvement in a mouse model of Alzheimer's type: possible involvement of BDNF-H
    Chen L; Shi R; She X; Gu C; Chong L; Zhang L; Li R
    Fundam Clin Pharmacol; 2020 Dec; 34(6):697-707. PubMed ID: 32484999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-N-ethyl Carboxamidoadenosine Stimulates Adenosine-2b Receptor-Mediated Mitogen-Activated Protein Kinase Pathway to Improve Brain Mitochondrial Function in Amyloid Beta-Induced Cognitive Deficit Mice.
    Semwal BC; Garabadu D
    Neuromolecular Med; 2020 Dec; 22(4):542-556. PubMed ID: 32926328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death.
    Wang X; Hu X; Yang Y; Takata T; Sakurai T
    Brain Res; 2016 Jul; 1643():1-9. PubMed ID: 27130898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective Effects of Rhynchophylline Against Aβ
    Jiang P; Chen L; Xu J; Liu W; Feng F; Qu W
    Neurochem Res; 2021 Sep; 46(9):2439-2450. PubMed ID: 34170454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
    Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
    Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of GPR17 with cangrelor improves cognitive impairment and synaptic deficits induced by Aβ
    Jin S; Wang X; Xiang X; Wu Y; Hu J; Li Y; Lin Dong Y; Tan Y; Wu X
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108335. PubMed ID: 34781121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plumbagin ameliorates memory dysfunction in streptozotocin induced Alzheimer's disease via activation of Nrf2/ARE pathway and inhibition of β-secretase.
    Nakhate KT; Bharne AP; Verma VS; Aru DN; Kokare DM
    Biomed Pharmacother; 2018 May; 101():379-390. PubMed ID: 29501041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease.
    Fragoulis A; Siegl S; Fendt M; Jansen S; Soppa U; Brandenburg LO; Pufe T; Weis J; Wruck CJ
    Redox Biol; 2017 Aug; 12():843-853. PubMed ID: 28448946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cAMP analog attenuates beta-amyloid (1-42)-induced mitochondrial dysfunction and spatial learning and memory deficits.
    Aghsami M; Sharifzadeh M; Sepand MR; Yazdankhah M; Seyednejad SA; Pourahmad J
    Brain Res Bull; 2018 Jun; 140():34-42. PubMed ID: 29605485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orientin alleviates cognitive deficits and oxidative stress in Aβ1-42-induced mouse model of Alzheimer's disease.
    Yu L; Wang S; Chen X; Yang H; Li X; Xu Y; Zhu X
    Life Sci; 2015 Jan; 121():104-9. PubMed ID: 25497709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid beta (1-42) downregulates adenosine-2b receptors in addition to mitochondrial impairment and cholinergic dysfunction in memory-sensitive mouse brain regions.
    Semwal BC; Garabadu D
    J Recept Signal Transduct Res; 2020 Dec; 40(6):531-540. PubMed ID: 32496898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antiglycating effect and in vivo neuroprotective activity of Trigonelline in d-galactose induced cognitive impairment.
    Chowdhury AA; Gawali NB; Bulani VD; Kothavade PS; Mestry SN; Deshpande PS; Juvekar AR
    Pharmacol Rep; 2018 Apr; 70(2):372-377. PubMed ID: 29477946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by Aβ peptides in animal model of Alzheimer's disease.
    Rahman SO; Panda BP; Parvez S; Kaundal M; Hussain S; Akhtar M; Najmi AK
    Biomed Pharmacother; 2019 Feb; 110():47-58. PubMed ID: 30463045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.